methyl 5-(1-cyclopropanecarbonyl-1,2,3,4-tetrahydroquinolin-7-yl)-3-oxo-2H,3H,5H-pyrazolo[4,3-c]pyridine-7-carboxylate

Compound number:
MolPort-039-060-191
IUPAC:
methyl 5-(1-cyclopropanecarbonyl-1,2,3,4-tetrahydroquinolin-7-yl)-3-oxo-2H,3H,5H-pyrazolo[4,3-c]pyridine-7-carboxylate
IUPAC traditional:
methyl 5-(1-cyclopropanecarbonyl-3,4-dihydro-2H-quinolin-7-yl)-3-oxo-2H-pyrazolo[4,3-c]pyridine-7-carboxylate
SMILES:
COC(=O)c1cn(cc2c1n[nH]c2=O)-c1ccc2CCCN(C(=O)C3CC3)c2c1
InChI key:
LSRIANUCSTWHKB-UHFFFAOYSA-N
Molecular formula:
C21H20N4O4
Molecular weight: 392.415
Solubility: not available

Marketplace Offers

S&H to USA: 140.00 USD
S&H to World: 180.00 USD

Supplier Catalogue Data


Catalog: Screening compound Ships out: 10 business days Purity: 92 - 98%
Last updated: last month In warehouse: 300.00 mg
Pack size Ships out Price Qty
3 micromol March 13, 2020 40.00 USD
ADD TO CART
5 micromol March 13, 2020 44.00 USD
ADD TO CART
10 micromol March 13, 2020 75.00 USD
ADD TO CART

More Information

Compound Identifiers
Compound number: MolPort-039-060-191

Names, Synonyms and 3rd Party Identifiers
Name: ZINC000253409379
methyl 5-(1-(cyclopropanecarbonyl)-1,2,3,4-tetrahydroquinolin-7-yl)-3-oxo-3,5-dihydro-2H-pyrazolo[4,3-c]pyridine-7-carboxylate

InChI
InChI: 1S/C21H20N4O4/c1-29-21(28)16-11-24(10-15-18(16)22-23-19(15)26)14-7-6-12-3-2-8-25(17(12)9-14)20(27)13-4-5-13/h6-7,9-11,13H,2-5,8H2,1H3,(H,23,26)
InChI key: LSRIANUCSTWHKB-UHFFFAOYSA-N

Calculated Properties
Molecular formula: C21H20N4O4
Molecular weight: 392.415

Other

Sales contact

+1 215 717 7447

+371 67790398

sales@molport.com


Our customer services department will be happy to help you Monday to Friday 7 a.m. to 9 p.m. GMT (2 a.m. - 4 p.m. EST).


2020 MolPort, v3.5, release date 34-02-2020 17:00 (+0200). All rights reserved.
This website or its third-party tools use cookies, which are necessary to its functioning and require to achieve the purposes illustrated in the Cookie Policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the Cookie Policy. By clicking on Agree and closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.